Maria Kavallaris

Research interests

Publications

• A translational framework to DELIVER nanomedicines to the clinic

  Nature Nanotechnology · 2024 · 10.1038/s41565-024-01754-7

• Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy

  Theranostics · 2022 · 10.7150/thno.69682

• Frontiers in the treatment of glioblastoma: Past, present and emerging

  Advanced Drug Delivery Reviews · 2021 · 10.1016/j.addr.2021.01.012

• Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion

  Cancer Research · 2020 · 10.1158/0008-5472.can-20-0471

• Nucleic acid hybridization on an electrically reconfigurable network of gold-coated magnetic nanoparticles enables microRNA detection in blood

  Nature Nanotechnology · 2018 · 10.1038/s41565-018-0232-x

• Minimum information reporting in bio–nano experimental literature

  Nature Nanotechnology · 2018 · https://doi.org/10.1038/s41565-018-0246-4

• Biologically Targeted Magnetic Hyperthermia: Potential and Limitations

  Frontiers in Pharmacology · 2018 · 10.3389/fphar.2018.00831

• An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance

  International Journal of Molecular Sciences · 2017 · 10.3390/ijms18071434

• Microtubules and Their Role in Cellular Stress in Cancer

  Frontiers in Oncology · 2014 · 10.3389/fonc.2014.00153

• Movers and shakers: cell cytoskeleton in cancer metastasis

  British Journal of Pharmacology · 2014 · 10.1111/bph.12704

• Role of pancreatic stellate cells in chemoresistance in pancreatic cancer

  Frontiers in Physiology · 2014 · 10.3389/fphys.2014.00141

• Using Fluorescence Lifetime Imaging Microscopy to Monitor Theranostic Nanoparticle Uptake and Intracellular Doxorubicin Release

  ACS Nano · 2013 · 10.1021/nn404407g

• β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma

  British Journal of Cancer · 2013 · https://doi.org/10.1038/bjc.2013.205

• Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment

  Oncotarget · 2011 · 10.18632/oncotarget.343

• Microtubules and resistance to tubulin-binding agents

  Nature reviews. Cancer · 2010 · https://doi.org/10.1038/nrc2803

• Metronomic chemotherapy: new rationale for new directions

  Nature Reviews Clinical Oncology · 2010 · 10.1038/nrclinonc.2010.82

• Integrative analysis of RUNX1 downstream pathways and target genes

  BMC Genomics · 2008 · 10.1186/1471-2164-9-363

• Microtubules: A dynamic target in cancer therapy

  IUBMB Life · 2008 · 10.1002/iub.25

• Acid-Labile Core Cross-Linked Micelles for pH-Triggered Release of Antitumor Drugs

  Biomacromolecules · 2008 · 10.1021/bm800043n

• Class III β-Tubulin Mediates Sensitivity to Chemotherapeutic Drugs in Non–Small Cell Lung Cancer

  Cancer Research · 2007 · 10.1158/0008-5472.can-07-0509

• The role of β-tubulin isotypes in resistance to antimitotic drugs

  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2001 · 10.1016/s0304-419x(00)00022-6

• Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells.

  PubMed · 2001

• Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells

  Cell Death and Differentiation · 2000 · 10.1038/sj.cdd.4400597

• Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol

  British Journal of Cancer · 1999 · 10.1038/sj.bjc.6690507

• Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.

  Journal of Clinical Investigation · 1997 · https://doi.org/10.1172/jci119642

Current projects

No projects listed.